Adenocarcinoma grows in the tissue of the prostate gland, but other types of cancer can also start in the prostate or spread ...

Small bowel neuroendocrine cancers are rare cancers ... People cope differently with cancer and want different information. Survival depends on many factors. So no one can tell you exactly how long ...

Cabozantinib improves progression-free survival (PFS) in patients with advanced extrapancreatic neuroendocrine tumors and pancreatic neuroendocrine tumors compared with placebo. Cabozantinib ...

Furthermore, the researchers used univariate and multivariate analyses to show that FDG-PET could be used to predict survival in patients with neuroendocrine tumors. “As a rare type of cancer it ...

But when it came to the secondary endpoint of interim overall survival (OS), the ITM-11 cohort reached 63.4 months while the ...

On International Women's Day 2025, learn about oncofertility, a discipline that combines oncology and reproductive ...

The FDA is expected to decide on treatments for dry eye disease, neuroendocrine tumors, chronic spontaneous urticaria, Barth syndrome, and migraine.

NETs and NECs are very different. So it is important to know which one you have. Talk to your doctor or specialist nurse if you are not sure. Small bowel neuroendocrine tumours need different ...

In this randomized controlled trial, cabozantinib significantly improved progression-free survival in patients with ...